Article Versions Notes

Iglesias J, Vassallo A, Ilagan J, Ang SP, Udongwo N, Mararenko A, Alshami A, Patel D, Elbaga Y, Levine JS. Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with Tocilizumab and Corticosteroids. Biomedicines. 2023; 11(3):845. https://doi.org/10.3390/biomedicines11030845

Iglesias, Jose, Andrew Vassallo, Justin Ilagan, Song Peng Ang, Ndausung Udongwo, Anton Mararenko, Abbas Alshami, Dylon Patel, Yasmine Elbaga, and Jerrold S. Levine. 2023. "Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with Tocilizumab and Corticosteroids" Biomedicines 11, no. 3: 845. https://doi.org/10.3390/biomedicines11030845

Iglesias, J., Vassallo, A., Ilagan, J., Ang, S. P., Udongwo, N., Mararenko, A., Alshami, A., Patel, D., Elbaga, Y., & Levine, J. S. (2023). Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with Tocilizumab and Corticosteroids. Biomedicines, 11(3), 845. https://doi.org/10.3390/biomedicines11030845